Janux Therapeutics, Inc. - COM (JANX)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
45.6M
Holdings value Q3 2024
$2.07B
Value change Q3 2024
+$43.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
157
Number of buys Q3 2024
85
Number of sells Q3 2024
-74
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 45.6M $2.07B +$43.7M $45.43 159
2024 Q2 44.7M $1.87B +$108M $41.89 152
2024 Q1 42.3M $1.59B +$333M $37.65 117
2023 Q4 33.5M $360M -$17.2M $10.73 64
2023 Q3 35.1M $354M +$45.5M $10.08 57
2023 Q2 30.5M $362M -$409K $11.87 54
2023 Q1 30.5M $370M +$18.6M $12.10 48
2022 Q4 29M $381M -$7.76M $13.17 49
2022 Q3 29.5M $400M +$8.92M $13.54 45
2022 Q2 28.9M $353M +$6.3M $12.21 43
2022 Q1 28.4M $407M +$11.4M $14.34 46
2021 Q4 27.5M $542M +$19.1M $19.73 46
2021 Q3 26.5M $571M +$35.5M $21.63 44
2021 Q2 24.7M $614M +$614M $24.95 29